Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Saved in:
| 企業作者: | |
|---|---|
| 其他作者: | |
| 格式: | 電子 電子書 |
| 語言: | English |
| 出版: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| 版: | 1st ed. 2011. |
| 叢編: | Current Topics in Microbiology and Immunology,
344 |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1007/978-3-642-14136-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|